Equibles does not estimate personal net worth.
Get an email with a short summary when Camp4 Therapeutics Corp publishes a filing, an earnings call transcript or a press release.
Get CAMP alertsKelly Gold is recorded as CFO at Camp4 Therapeutics Corp (CAMP). The newest filing on record that lists Kelly Gold as CFO at Camp4 Therapeutics Corp (CAMP) is dated April 23, 2026. The proxy statement of Camp4 Therapeutics Corp reports total compensation of $1,846,733 for Kelly Gold in fiscal 2025, including a base salary of $465,000. Disclosed compensation is on record for 3 fiscal years. Kelly Gold has spoken on 1 investor event across 1 company, most recently for Camp4 Therapeutics Corp on April 13, 2026. Camp4 Therapeutics Corp is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Camp4 Therapeutics Corp includes Josh Mandel-Brehm (CEO and Board Member), Doug Williams (Chairman), Amir Nashat (Board Member) and 7 others.
“And so CAMP4 is, in short, using antisense oligonucleotides to upregulate gene expression. and we are doing this by targeting a relatively newly identified species of RNA that we refer to as regulatory RNA.”
Start not stated–present
Last confirmed April 23, 2026
Biotechnology · Healthcare
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Camp4 Therapeutics Corp (CAMP) | Chief Financial Officer | $465,000 | $1,846,733 |
| 2024 | Camp4 Therapeutics Corp (CAMP) | Chief Financial Officer | $433,333 | $1,310,523 |
| 2023 | Camp4 Therapeutics Corp (CAMP) | Chief Financial Officer | $425,000 | $628,834 |
